Cellectar Biosciences Inc (CLRB) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cellectar Biosciences Inc   (NASDAQ: CLRB)


Cellectar Biosciences Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cellectar Biosciences Inc's ROI in the first quarter of 2026?
Cellectar Biosciences Inc recorded a cumulative net loss of $-21 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -243.65%.

Within the Healthcare sector 799 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 4278, from total ROI ranking in the fourth quarter of 2025 at 4944.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -39.45 % -36.83 % 44.12 % 805.72 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 10 10 8 10
Return On Investment (TTM) -243.65 % -228.91 % -172.02 % -229.95 % -173.74 %
CLRB's Overall Ranking # 4278 # 4944 # 4315 # 4426 # 4430
Seq. Investment Change TTM -10.15 % -13.13 % -13.32 % -10.5 % -6.26 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -21 -22 -19 -29 -25

CLRB Company Profile >> Back to CLRB Roi Comparisons >> See Annual CLRB Return On Investment



Return On Investment CLRB's Ranking
Within: No.
Industry # 377
Sector # 800
Overall # 4278

Return On Investment Statistics
High Average Low
-46.39 %
-236.97 %
-2794.85 %
(Sep 30 2021)   (Jun 30 2024)







Financial Statements
Cellectar Biosciences Inc's I. Quarter Investments $ 6 Millions CLRB's Balance sheet
Cellectar Biosciences Inc's I. Quarter Income $ -6 Millions Quarterly CLRB's Income Statement
CLRB's Income by Division See CLRB's Income by Division


CLRB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 10 16 -14 16 33
Y / Y Investment Growth -38.34 % - - -53.07 % -39.69 %
Net Income in Millions -22 -45 -43 -29 -24
Y / Y Net Income Growth - - - - -
Annual Return On Investment -219.69 % -277.14 % - -184.43 % -73 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CLRB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CLRB's Competitors
Subscribers only: Roi for Cellectar Biosciences Inc's Suppliers
Subscribers only: Return On Investment for CLRB's Customers

Other Ratios
CLRB's Roa CLRB's Inventory Turnover Ratio CLRB's Growth Rates CLRB's Dividend Statistics
CLRB's Profitability Ratios CLRB's Asset Turnover Ratio CLRB's Dividend Growth
CLRB's Roe CLRB's Valuation Ratios CLRB's Financial Strength Ratios CLRB's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T17:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.